(Q38214812)

31 August 2017

title

Pathology of IgA nephropathy (English)

1 reference

31 August 2017

0 references

Ian S D Roberts

1

1 reference

31 August 2017

language of work or name

English

0 references

publication date

27 May 2014

1 reference

Nature Reviews Nephrology

31 August 2017

published in

1 reference

31 August 2017

volume

10

1 reference

31 August 2017

issue

8

1 reference

31 August 2017

page(s)

445-454

1 reference

A retrospective analysis of the natural history of primary IgA nephropathy worldwide

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Regression of IgA nephropathy: a repeat biopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Mesangial C4d deposition: a new prognostic factor in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Race/ethnicity and disease severity in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Predicting progression in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Local macrophage proliferation in human glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Grading of acute and chronic renal lesions in Henoch-Schönlein purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Clinicopathological associations in mesangial IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

IGA nephropathy: a retrospective evaluation of prognostic indices in 176 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Tubular lesions determine prognosis of IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Mast cells: the forgotten cells of renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Validation study of oxford classification of IgA nephropathy: the significance of extracapillary proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

The use of the Oxford classification of IgA nephropathy to predict renal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

The Oxford classification as a predictor of prognosis in patients with IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Validation of the Oxford classification of IgA nephropathy: a single-center study in Korean adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Severity of nephrotic IgA nephropathy according to the Oxford classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Validation of the Oxford classification of IgA nephropathy for pediatric patients from China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Usefulness of Oxford classification in assessing immunoglobulin A nephropathy after transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Outcome of IgA nephropathy in adults graded by chronic histological lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

IgA nephropathy in blacks and Indians of Natal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Pathogenesis of IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Frequency of mesangial IgA deposits in a non-selected autopsy series

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

IgA nephropathy in children: significance of glomerular basement membrane deposition of IgA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Significance of IgA deposits on the glomerular capillary walls in IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Idiopathic IgA mesangial nephropathy: immunohistological features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

The immunohistology of IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

International variation in the interpretation of renal transplant biopsies: report of the CERTPAP Project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Characterization and quantification of proliferating cell patterns in endocapillary proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Identification of alternatively activated macrophages in new-onset paediatric and adult immunoglobulin A nephropathy: potential role in mesangial matrix expansion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Prognostic indicators in children with IgA nephropathy--report of the Southwest Pediatric Nephrology Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Morphologic high-risk factors in IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Clinicopathologic study on prognostic markers in IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Clinicopathological features and the prognosis of IgA nephropathy in Japanese children on long-term observation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Histological differences in new-onset IgA nephropathy between children and adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Significance of CD25 positive cells and macrophages in noncrescentic IgA nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

IgA nephropathy: morphologic predictors of progressive renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Validation of the Oxford classification of IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Validity of the Oxford classification of IgA nephropathy in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

The Oxford classification of IgA nephropathy: a retrospective analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Cellular crescents and segmental glomerular necrosis in IgA nephropathy are indicative of the beneficial effects of corticosteroid therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Recurrent immunoglobulin A nephropathy after renal transplantation: a significant contributor to graft loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

IgA nephropathy recurs early in the graft when assessed by protocol biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.92

Treatment of vasculitic IgA nephropathy

31 March 2020

1 reference

12 December 2020

Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity

1 reference

12 December 2020

IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature.

1 reference

12 December 2020

Glomerular and tubular C4d depositions in IgA nephropathy: relations with histopathology and with albuminuria

1 reference

12 December 2020

Schönlein-Henoch nephritis

1 reference

12 December 2020

Prognostic indicators in idiopathic IgA mesangial nephropathy

1 reference

12 December 2020

Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients

1 reference

12 December 2020

Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.

1 reference

12 December 2020

An important role of glomerular segmental lesions on progression of IgA nephropathy: a multivariate analysis

1 reference

12 December 2020

Histomorphometric correlates of renal failure in IgA nephropathy.

1 reference

12 December 2020

Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2014.92

1 reference

Dimensions Publication ID

31 August 2017

1016117821

0 references

1 reference